312 related articles for article (PubMed ID: 34293320)
1. Advanced mesoporous silica nanocarriers in cancer theranostics and gene editing applications.
Živojević K; Mladenović M; Djisalov M; Mundzic M; Ruiz-Hernandez E; Gadjanski I; Knežević NŽ
J Control Release; 2021 Sep; 337():193-211. PubMed ID: 34293320
[TBL] [Abstract][Full Text] [Related]
2. A Review on Recent Technologies and Patents on Silica Nanoparticles for Cancer Treatment and Diagnosis.
Gupta A; Kushwaha SS; Mishra A
Recent Pat Drug Deliv Formul; 2020; 14(2):126-144. PubMed ID: 32928094
[TBL] [Abstract][Full Text] [Related]
3. Recent Developments in Mesoporous Silica Nanoparticles for Tumor Theranostic Applications.
Wang X; Zheng M; Raza F; Liu Y; Wei Y; Qiu M; Su J
Curr Pharm Des; 2022; 28(2):151-164. PubMed ID: 34766889
[TBL] [Abstract][Full Text] [Related]
4. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
Zhang W; Liu M; Liu A; Zhai G
Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
[TBL] [Abstract][Full Text] [Related]
5. Mesoporous Silica Nanoparticles as Carriers for Biomolecules in Cancer Therapy.
Küçüktürkmen B; Rosenholm JM
Adv Exp Med Biol; 2021; 1295():99-120. PubMed ID: 33543457
[TBL] [Abstract][Full Text] [Related]
6. In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles.
Chen Y; Chen H; Shi J
Adv Mater; 2013 Jun; 25(23):3144-76. PubMed ID: 23681931
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in mesoporous silica nanoparticle-based targeted drug-delivery systems for cancer therapy.
Li Y; Deng G; Hu X; Li C; Wang X; Zhu Q; Zheng K; Xiong W; Wu H
Nanomedicine (Lond); 2022 Aug; 17(18):1253-1279. PubMed ID: 36250937
[TBL] [Abstract][Full Text] [Related]
8. Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis.
She X; Chen L; Yi Z; Li C; He C; Feng C; Wang T; Shigdar S; Duan W; Kong L
Mini Rev Med Chem; 2018; 18(11):976-989. PubMed ID: 27145854
[TBL] [Abstract][Full Text] [Related]
9. Controllable synthesis of versatile mesoporous organosilica nanoparticles as precision cancer theranostics.
Cheng Y; Jiao X; Fan W; Yang Z; Wen Y; Chen X
Biomaterials; 2020 Oct; 256():120191. PubMed ID: 32593907
[TBL] [Abstract][Full Text] [Related]
10. A review on the latest developments of mesoporous silica nanoparticles as a promising platform for diagnosis and treatment of cancer.
Ahmadi F; Sodagar-Taleghani A; Ebrahimnejad P; Pouya Hadipour Moghaddam S; Ebrahimnejad F; Asare-Addo K; Nokhodchi A
Int J Pharm; 2022 Sep; 625():122099. PubMed ID: 35961417
[TBL] [Abstract][Full Text] [Related]
11. Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery.
Li Z; Zhang Y; Feng N
Expert Opin Drug Deliv; 2019 Mar; 16(3):219-237. PubMed ID: 30686075
[TBL] [Abstract][Full Text] [Related]
12. Multifunctional Mesoporous Silica Nanoparticles for Cancer Therapy and Imaging.
Dilnawaz F
Curr Med Chem; 2019; 26(31):5745-5763. PubMed ID: 29714137
[TBL] [Abstract][Full Text] [Related]
13. Multifunctional mesoporous silica nanoparticles for combined therapeutic, diagnostic and targeted action in cancer treatment.
Rosenholm JM; Sahlgren C; Lindén M
Curr Drug Targets; 2011 Jul; 12(8):1166-86. PubMed ID: 21443474
[TBL] [Abstract][Full Text] [Related]
14. Recent advancements in mesoporous silica nanoparticles towards therapeutic applications for cancer.
Li T; Shi S; Goel S; Shen X; Xie X; Chen Z; Zhang H; Li S; Qin X; Yang H; Wu C; Liu Y
Acta Biomater; 2019 Apr; 89():1-13. PubMed ID: 30797106
[TBL] [Abstract][Full Text] [Related]
15. Mesoporous silica nanoparticles in drug delivery and biomedical applications.
Wang Y; Zhao Q; Han N; Bai L; Li J; Liu J; Che E; Hu L; Zhang Q; Jiang T; Wang S
Nanomedicine; 2015 Feb; 11(2):313-27. PubMed ID: 25461284
[TBL] [Abstract][Full Text] [Related]
16. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
[TBL] [Abstract][Full Text] [Related]
17. Theragnostic potentials of core/shell mesoporous silica nanostructures.
Ravindran Girija A; Balasubramanian S
Nanotheranostics; 2019; 3(1):1-40. PubMed ID: 30662821
[TBL] [Abstract][Full Text] [Related]
18. Preparation and identification of multifunctional mesoporous silica nanoparticles for in vitro and in vivo dual-mode imaging, theranostics, and targeted tracking.
Chan MH; Lin HM
Biomaterials; 2015 Apr; 46():149-58. PubMed ID: 25678124
[TBL] [Abstract][Full Text] [Related]
19. Multifunctional mesoporous silica nanoparticles for biomedical applications.
Xu B; Li S; Shi R; Liu H
Signal Transduct Target Ther; 2023 Nov; 8(1):435. PubMed ID: 37996406
[TBL] [Abstract][Full Text] [Related]
20. Mesoporous silica nanoparticles: facile surface functionalization and versatile biomedical applications in oncology.
Huang R; Shen YW; Guan YY; Jiang YX; Wu Y; Rahman K; Zhang LJ; Liu HJ; Luan X
Acta Biomater; 2020 Oct; 116():1-15. PubMed ID: 32911102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]